The Andy Hill Cancer Research Endowment (CARE), a public-private partnership that supports cancer research in Washington, today announced grant awards totaling $1.15 million to leading research scientists advancing cancer research in the state. The CARE Breakthrough Research program funds innovative, cross-disciplinary research and multi-institution collaborations that aim to find the next big discovery in cancer research. Grants were awarded to…
Read More
Barbara Stephanus, a longtime donor to Fred Hutchinson Cancer Research Center, has gifted not one but two endowed chairs to support the center’s science: Dr. Denise Galloway, who studies the role of human viruses in cancer development, is the recipient of the Paul Stephanus Memorial Endowed Chair, named in honor of Barbara Stephanus’ late husband, who worked in real estate.…
Read More
Two University of Washington researchers are among the 416 new fellows of the American Association for the Advancement of Science, announced in November. Election as a fellow of the AAAS is an honor bestowed upon members by their peers, in recognition of their efforts to advance science or its applications. Terrance Kavanagh, a UW professor of environmental and occupational health sciences in…
Read More
Brain-computer interfaces have the potential to give patients better and more natural control over their prosthetic devices. Through this method, a chip in a patient’s brain picks up a thought — neural activity triggered by focusing on specific visual imagery — to move a joint and then transmits that signal to the prosthetic. This technology is not widely available yet,…
Read More

Dr. Cameron Howard Lee Named 2019 Helen Hay Whitney Fellow

Dr. Cameron Howard Lee, a postdoctoral fellow in the laboratory of Dr. Sue Biggins at Fred Hutchinson Cancer Research Center, has been named a 2019 Helen Hay Whitney fellow by the Helen Hay Whitney Foundation. The foundation provides independent postdoctoral research support to young biomedical scientists. Lee will use the three-year, $180,000 fellowship to investigate the potential relationship between protein production machinery and…
Read More
Launching a clinical trial is a lot like leaping from an airplane, says Colette Chaney: “You’re scared, you’re exhilarated and you’re hoping for a positive outcome.” The longtime clinical research nurse would know. She’s stood in front of an open door on a plane, steeling herself to skydive. And she’s infused patients with revved-up T cells that had never before…
Read More

Dr. Sita Kugel Named 2018 V Scholar

Fred Hutchinson Cancer Research Center pancreatic cancer researcher Dr. Sita Kugel has been named a 2018 V Scholar by the V Foundation for Cancer Research. The two-year, $200,000 award will support Kugel’s goal of developing a targeted therapy for an aggressive subtype of pancreatic cancer. “I am incredibly humbled and honored to receive this recognition from the V Foundation,” said Kugel, an assistant…
Read More
Fred Hutchinson Cancer Research Center’s Alex Salter was listed on Tuesday as a Forbes “30 Under 30,” an annual who’s-who of influencers under age 30 in the U.S. and Canada. The M.D./Ph.D. student in the lab of Dr. Stan Riddell at Fred Hutch made the list of 30 standouts in the health care category. The magazine says that the honorees in 20 categories represent “a…
Read More

Two New Grants to Fuel Metastatic Breast Cancer Research

Two early-career investigators at Fred Hutchinson Cancer Researcher Center have received grants that will fuel their research into metastatic breast cancer. Dr. Erica Goddard, a postdoctoral research fellow in Dr. Cyrus Ghajar’s Laboratory for the Study of Metastatic Microenvironments, won a Breakthrough Fellowship Award from the Department of Defense Breast Cancer Research Program. She will receive a total of $528,000 over three…
Read More
Eight researchers in the Fred Hutchinson/University of Washington Cancer Consortium have received grants totaling nearly $2 million from the Breast Cancer Research Foundation, or BCRF, funding that will continue to fuel their research through 2019. Most of the grants will go toward new therapies for patients with metastatic cancers. The grants were part of a record-breaking $63 million given out this…
Read More